BridgeMD
New treatment option for Young Onset Dementia
Official title Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
ClinicalTrials.gov ID: NCT07018726
What this study is testing
- What it's testing
- The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to address the unmet need of preventing chronic emotional distress in YOD dyads through a feasible, acceptable and credible program, and ideally enhance resiliency and improve wellbeing and quality of life in both members of the dyad.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Between the ages of 18-65 at the time of enrollment [both patient and care-partner]
- Diagnosis of young-onset dementia (FTD, PPA, AD, PCA, etc.) with symptom onset prior to age 65 [patient]
- A designated care-partner willing and interested to participate [both patient and care-partner]
- Received YOD diagnosis in the past 6 month [patient]
- English fluency and literacy [both patient and care-partner]
You likely can't join if
- An additional, terminal diagnosis such as cancer
- Lack of access to internet and/or a device with a camera
- Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use
See the full eligibility criteria
- Between the ages of 18-65 at the time of enrollment [both patient and care-partner]
- Diagnosis of young-onset dementia (FTD, PPA, AD, PCA, etc.) with symptom onset prior to age 65 [patient]
- A designated care-partner willing and interested to participate [both patient and care-partner]
- Received YOD diagnosis in the past 6 month [patient]
- English fluency and literacy [both patient and care-partner]
- Cognitive ability to understand study and research protocol in order to consent to study participation per referring neurologist [both patient and care-partner]
- Patient and/or caregiver exhibit emotional distress on screening (using HADS D and/or HADS A scores \> 7)
- An additional, terminal diagnosis such as cancer
- Lack of access to internet and/or a device with a camera
- Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.